InVitro International
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
330 E Orangethorpe Ave Ste D, Placentia,...Phone Number
(800) 246-8487Website
www.invitrointl.comRevenue
<$5 MillionStock Symbol
IVROIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About InVitro International
InVitro International specializes in the development and marketing of non-animal testing technologies, focusing on in vitro assay kits and systems for assessing eye and skin irritation and toxicity. Their proprietary products, such as the Irritection Assay System and Corrositex, provide accurate and cost-effective safety testing solutions that comply with global standards like OECD, GHS, and REACH. The company aims to advance in-vitro science and promote cruelty-free testing alternatives, serving clients worldwide with their innovative laboratory services. Established in 1985 and headquartered in Placentia, CA, InVitro International is committed to making non-animal testing a recognized standard in safety assessments.Explore more
InVitro International Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is InVitro International your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if InVitro International has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if InVitro International is spiking on competitors!
Click to see if InVitro International had a recent Job posting/layoffs
Product Launch: Get notified when InVitro International launches new products
Earning: See what the market has to say on InVitro International recently announced quarterly report
InVitro International, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at InVitro International
Funding: Get notified immidiatlly once InVitro International has new funding data
Recommended Actions
Reach out to Masked Content who joined InVitro International as Masked Content
Find 2 more new buyers
Compare Similar Companies to InVitro International
Compare insights from companies similar to InVitro International, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
InVitro International is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
InVitro International is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about InVitro International.
InVitro International financials insights
Gather financial insights about InVitro International, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$101K
InVitro International Tech Stack
A closer look at the technologies used by InVitro International
Most Recent Scoops
Project
A high-level source has indicated that the organization is planning to begin initiatives related to customer experience, service & success within the next six months.
Customer Service
Pain Point
Project
A high-level source has indicated that the organization is planning remediate challenges related to cross-sell and upsell.
Project
A high-level source has indicated that the organization is planning to begin initiatives related to SEC reporting within the next six months.
Compliance
Project
A high-level source has indicated that the organization is planning to begin initiatives related to customer data platform (CDP) within the next six months.
Database, Software
Project
Accounting
InVitro International News & Media
IVRO Announces Fiscal Q #3 2023 Results While Continuing M&A Strategy to Make Non-Animal Testing Famous
Placentia, California--(Newsfile Corp. - August 9, 2023) - Today, InVitro International (OTC Pink: IVRO), the 38 year pioneer developer and marketer of animal free testing methods, announced Fiscal 2023 third quarter sales of $199,855, off 16% from prior year's third quarter. However, the net loss of $13,162 was a 58% improvement over last year's $28,938 third quarter loss. FY '23 YTD losses of $47,482 include proposed merger related costs. YTD FY '23 sales of $608,195IVRO Advances Core Strategy to Make Non-Animal Testing Famous, Announces Fiscal Q2 2023 Results
Placentia, California--(Newsfile Corp. - May 11, 2023) - Today InVitro International (OTC Pink: IVRO), the 38 year pioneer developer and marketer of animal free testing methods, announced Fiscal 2023 second quarter sales of $199,090, off 23% from the same quarter Fiscal 2022; YTD sales are now off 8%. Net loss for this FY '23 quarter of $3,356 was 86% less than last year's loss of $24.6K. Proposed merger related costs have contributed to both FiscalIVRO Advances Core Strategy to Make Non-Animal Testing Famous, Announces Fiscal Q1 2023 Results
Placentia, California--(Newsfile Corp. - February 8, 2023) - Today InVitro International (OTC Pink: IVRO), the 37 year pioneer developer and marketer of animal free testing methods, announced first fiscal quarter sales of $209,250, an increase of 14% over the same quarter last year. An operating loss of $31,169 was approximately 49% less than the prior years' first fiscal quarter operating loss and partially attributed to initial M&A activity. Our M&A activity has moved forward smoothly...IVRO Continues to Help Make Non-Animal Testing Famous, Releases Fiscal 2022 Results
Placentia, California--(Newsfile Corp. - December 8, 2022) - InVitro International (OTC Pink: IVRO) today announced full year FY2022 sales results of $853,511 (-15%) and net income of $21,276 (-79%).CEO W. Richard Ulmer remarked: "We remain extremely enthusiastic regarding the future of NON-Animal testing despite somewhat disappointing, Covid related, FY '22 financial results. Our October '22 announcement of a Letter of Intent to merge with a well-established, privately owned laboratory adds gre
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding InVitro International
Sign Up For FreeTo access detailed company insights
InVitro International specializes in the development and marketing of non-animal testing technologies, focusing on in vitro assay kits and systems for assessing eye and skin irritation and toxicity. Their proprietary products, such as the Irritection Assay System and Corrositex, provide accurate and cost-effective safety testing solutions that comp... Read More
